EMA Authorised: Cymbalta (duloxetine) — Eli Lilly Nederland B.V.

View source ↗

Summary

Cymbalta (duloxetine) has been authorized by the EMA for anxiety disorders, diabetic neuropathy, and major depressive disorder with Eli Lilly Nederland B.V. as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Diabetic Neuropathy
• Major Depressive Disorder

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Status: Authorised. Therapeutic area: Anxiety Disorders;Diabetic Neuropathies;Depressive Disorder, Major. MAH: Eli Lilly Nederland B.V.. Decision date: 20/06/2024